Home › Identities › Transfeminine
Transfeminine
Transfeminine is a spectrum umbrella over trans woman that avoids the sharp claim "I am a woman" and, according to critics, merges clinically distinct subgroups under one label. It leaves out Blanchard's division of men with gender dysphoria into a homosexual and a non-homosexual type, in which autogynephilia is a feature.
Definition according to proponents
A person of male sex at birth with a female or feminine self-image at any point on the spectrum. Includes trans women, non-binary feminine persons, crossdressers with an identity claim, and persons with partial identification. The umbrella carries no diagnostic criterion of its own; it is a collective label for disparate subgroups.
Origin: spectrum jargon
The term belongs to the spectrum terminology around gender identity; the WPATH SOC 8 guideline uses the term "transfeminine" (source). Ray Blanchard wrote that heterosexual, asexual and bisexual transsexual men are more similar to each other than to the homosexual type (source). See Blanchard typology.
In 2005 Blanchard described how he had introduced the term autogynephilia (love of oneself as a woman) for men who are sexually aroused by the thought or image of themselves as a woman (source). J. Michael Bailey (2003) and Anne Lawrence (2013) wrote books on this theory.
Criticism: one label for different groups
By placing late-onset M-to-F and early homosexual M-to-F individuals under one spectrum label, the possibility of investigating their different epidemiologies, life trajectories and risk profiles separately is lost. For policy (sports, prisons, single-sex facilities) this is inevitably problematic: a single rule is created for groups that are in fact not comparable. A textbook example of circular reasoning — identity explains identity — and of unfalsifiability. There is no marker, only self-reporting.
The Cass Review (2024) calls the care of young people with gender dysphoria "an area of remarkably weak evidence" (source). Levine, Abbruzzese and Mason (2022) argue that the interventions in young people rest on very low-quality evidence and that a good informed-consent process is needed (source).
Treatment: hormones and surgery
Clinical pathways under the transfeminine umbrella vary widely: hormone therapy, mammoplasty, vaginoplasty and/or voice training. Cass (2024) recommends that NHS England set up services for 17- to 25-year-olds at each regional centre (source); SBU (2022) found the evidence insufficient to assess the effects of hormone treatment in young people and does not itself make recommendations (source). Hruz (2020) writes that high-quality scientific evidence on the effects of these interventions is generally lacking and argues for great caution (source). See detransition research and regret research.
Related identities
Trans woman — narrower claim.
Non-binary — umbrella.
Demigender — partial variant.
Transgender — broad umbrella.
Frequently Asked Questions
Yes, transfeminine is broader and also includes people who do not fully identify as women.
Blanchard (2005) described autogynephilia as sexual arousal at the thought or image of oneself as a woman and saw it as a common feature of non-homosexual transsexual men and transvestites. See autogynephilia.
Policy rules that take "transfeminine" as a category treat clinically different groups equally and thereby lose discriminatory power — particularly in sports and single-sex facilities.
The Cass Review (2024) calls the care of young people with gender dysphoria "an area of remarkably weak evidence" and recommends, among other things, that NHS England set up services for 17- to 25-year-olds at each regional centre.
The WPATH SOC 8 guideline uses the term "transfeminine".
Sources
- Blanchard, R. (2005). Early history of the concept of autogynephilia. Archives of Sexual Behavior, 34, 439–446.
- Bailey, J. M. (2003). The Man Who Would Be Queen. Joseph Henry Press.
- Lawrence, A. (2013). Men Trapped in Men's Bodies. Springer.
- Cass, H. (2024). Independent Review — Final Report.
- Levine, S. B., Abbruzzese, E. & Mason, J. W. (2022). Reconsidering informed consent for trans-identified children, adolescents, and young adults. Journal of Sex & Marital Therapy, 48(7), 706–727.
- Hruz, P. W. (2020). Deficiencies in scientific evidence for medical management of gender dysphoria. The Linacre Quarterly, 87(1), 34–42.